Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasms 1 Multiple Myeloma 1

Interventions

Dexamethasone 44 Lenalidomide 29 Bortezomib 23 daratumumab 22 pomalidomide 19 Cyclophosphamide 15 carfilzomib 14 Specimen Handling 14 Biopsy 14 Calcium Dobesilate 12 Magnetic Resonance Spectroscopy 10 talquetamab 9 isatuximab 9 Melphalan 8 iberdomide 7 fludarabine 7 belantamab mafodotin 6 dexamethasone acetate 5 dexamethasone 21-phosphate 5 auricularum 5 X-Rays 5 tocilizumab 4 selinexor 4 fludarabine phosphate 4 elotuzumab 4 Nuclear Medicine Department, Hospital 4 trametinib 3 dabrafenib 3 Whole-Body Irradiation 3 Thalidomide 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Multiple Myeloma × nirogacestat × 30 days × Clear all

NCT04722146 2026-06-05

MajesTEC-2

Janssen Research & Development, LLC

Phase 1 Active not recruiting

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡